Evaluation of Safety and Efficacy of Purgative Manna (Billinaster Drop) and Glycerin Suppository in Icterus of Healthy Term Newborns

ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)

Volume 12, 3 Issues, 2017

Download PDF Flyer

Current Drug Safety

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Dr. Seetal Dodd
University of Melbourne
Geelong, 3220

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Evaluation of Safety and Efficacy of Purgative Manna (Billinaster Drop) and Glycerin Suppository in Icterus of Healthy Term Newborns

Current Drug Safety, 9(1): 29-33.

Author(s): Razieh Fallah, Mohammad Ali Fallahzadeh and Mahmood Noori-Shadkam.

Affiliation: Shahid Sadoughi Hospital, Ave - Sina Blvd, Shahid Ghandi Blvd, Yazd, I.R. Iran.


Objective: The aim of the present study was to investigate safety and efficacy of billinaster drop and glycerin suppository in hyperbilirubinemia of healthy term newborns who had passage of first meconium.

Methods: In a randomized clinical trial, 90 neonates with total plasma bilirubin(TPB) level of 15–20mg/dL, were randomly assigned to be treated with alone phototherapy (control) or 5drop/kg of bilinaster drop every eight hours and phototherapy(B) or half of glycerin suppository every twelve hours and phototherapy(G). The primary outcomes were safety of drugs and efficacy in obtaining TPB of less than 14 mg/dL as measured at the beginning, 12, 24 and 48 hours after intervention. Secondary endpoint was hospitalization days.

Results: After 48 hours of intervention, achieving TPB of less than 14 mg/dL was seen in 50 %( N=15) in control group, 73.3 %( N=22) in B group and 86.7 %( N=26 neonates) in G group (P= 0.01).

Watery stool was seen in two neonates of glycerin group and safety of the treatments was not significantly different.

Mean of TPB 12 hours after beginning of phototherapy(mean±SD:14.38±2.27mg/dL in G, 15.97±1.96mg/dL in B and 16.67±1.77mg/dL in control), 24 hours after intervention(mean±SD:12.56 ±1.59mg/dL in G, 12.57±2.05mg/dL in B and 14.36±2.26mg/dL in control), 48 hours after intervention (mean±SD: 9.34 ± 1.6mg/dL in G, 9.96 ± 2.95mg/dL in B and 12.27 ± 2.4mg/dL in control) and mean of hospitalization days (mean± SD: 1.5 ± 0.4days in G, 1.7 ± 0.4days in B and 2.9 ± 1.1days in control) were significantly lower in glycerin and billinaster groups.

Conclusion: Bilinaster drop and glycerin suppository can be used as hazardless, efficient and cost effective drugs in treatment of neonatal hyperbilirubinemia.


Bilinaster, glycerin suppository, jaundice, neonate, purgative manna, term.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 1
First Page: 29
Last Page: 33
Page Count: 5
DOI: 10.2174/15748863113086660052

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science